News – Page 1095 – Endpoints News

FDA rejects Intarcia’s hotly promoted diabetes drug/device, citing manufacturing issues

8 years ago

Allergan’s tribal treaty in Restasis patent fight triggers a Congressional donnybrook

8 years ago

Mateon punts failed late-stage cancer drug, axes staffers; Medivir boosted by osteoarthritis data

8 years ago

Right after Trump blamed high drug prices on campaign cash, drugmakers gave more

8 years ago

GSK spinout NeRRe splits the pipeline, creates its own spinout

8 years ago

Oh, no we aren’t! AbbVie says it isn’t rethinking pricing pledge at all

8 years ago

Small is big: Pharma’s R&D brain drain continues as GSK’s Chris Carpenter jumps to upstart Rubius

8 years ago

No time for formalities, Acorda scraps FDA meeting in scramble to re-file CVT-301

8 years ago

Former Zacks biotech analyst Napodano charged with fraud after settling with SEC on insider trading cases

8 years ago

EMA warns HQ move may cause major turmoil, seriously delaying new drug approvals

8 years ago

Newly debuted biotech shoots for $40M IPO; Intellia touts new animal data on CRISPR/Cas9

8 years ago

In a damning indictment, FDA review scorns PTC’s Duchenne drug for repeated failures

8 years ago

Next-gen CAR-T, TCR player Autolus gains $80M for clinical trial work

8 years ago

Axovant's lead Alzheimer's drug flops in PhIII, ending an unlikely quest

8 years ago

Two young scientists bag $20M to perfect their CRISPR attack on disease-causing bacteria at upstart Eligo

8 years ago

Genocea shelves its lead drug, slashes staff and switches focus to trendy neoantigens

8 years ago

ProQR spotlights the most encouraging results from a mixed snapshot of efficacy for cystic fibrosis

8 years ago

The top 5 trends in biotech - #3: High valuations for attractive biotechs are a durable symptom of a thriving ...

8 years ago

J&J lines up its 4-in-1 HIV pill for FDA behind rivals from Gilead, GSK

8 years ago

Spark recruits gene therapy expert Mingozzi as new CSO; Fusion brings venture round to $46M; China OKs Gilead’s ...

8 years ago

Pfizer spins off drug orphans into a PhIII-ready startup backed by Bain to the tune of $103M

8 years ago

Puretech’s Gelesis flunks the FDA’s key measure of success for weight loss treatments

8 years ago

Visualize: What would these 11 biotech companies look like without immigrants?

8 years ago

Allergan caps a bad day with news the FDA has kicked back a supplemental application for cariprazine

8 years ago

First page Previous page 1092 1093 109410951096 1097 1098 Next page Last page